Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
04/2007
04/18/2007EP1425276B1 Heterocyclic carboxamides and their use as fungicides
04/18/2007CN1950354A Process for making n-sulfonated-amino acid derivatives
04/18/2007CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
04/18/2007CN1950334A Ortho substituted aryl or heteroaryl amide compounds
04/18/2007CN1948303A Method of synthesizing dehydro sodium acetate
04/18/2007CN1310836C Metallized mesoporous silicate and method of oxidation with the same
04/17/2007US7205415 Process for the preparation of simvastatin
04/17/2007US7205334 vacuolar-type (H+)-ATPase-inhibiting macrocyclic lactams belonging to the chondropsin class useful in cancer chemotherapy
04/17/2007US7205333 Therapy for influenza virus; inhaler
04/17/2007CA2141589C Antiretroviral enantiomeric nucleotide analogs
04/12/2007WO2007038829A1 Method of drug design
04/12/2007US20070083061 Etherification of 4-Methoxy-6-trifluoromethylpyran-2-one with dimethyl sulfate, converting to the alkyl ester with an alkali or alkaline earth metal alcoholate; chemical intermediate for insecticides
04/12/2007US20070083058 Process for the preparation of aliphatic primary alcohols and related intermediates in such process
04/12/2007CA2619457A1 Method of drug design
04/11/2007EP1440061B1 Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
04/11/2007CN1946680A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
04/11/2007CN1309709C C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
04/11/2007CN1309704C Anthranyl amides and their use as medicaments
04/10/2007US7202350 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives, are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/05/2007US20070078272 catalyzing the hydrogenation reaction in presence of a metal catalyst in alcohol solvent, starting dihydropyran-4-one or pyran-4-one; simple and easy process; intermediates of medicine, agricultural chemicals
04/05/2007US20070077618 heating an aqueous solution of 1,5-D-anhydrofructose at an acidic pH, in the presence of antioxidant selected from ascorbic acid, erythorbic acid, ethylenediamine tetraacetic acid and their salts
04/04/2007CN1942462A Chiral heptyne derivatives for the preparation of epothilones and processes for their preparation
04/04/2007CN1308316C Alpha-phenyl-beta-ketosulfone
03/2007
03/28/2007EP1765803A1 Quaternary salt ccr2 antagonists
03/28/2007EP1765794A1 Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives
03/28/2007EP1765354A1 Leptomycin compounds
03/28/2007EP1501777A4 Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts
03/28/2007CN1938258A Ester derivatives of rhein and their therapeutic use
03/27/2007US7196209 Continuous process for the preparation of fructopyranose sulfamate derivatives
03/27/2007CA2378002C Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
03/22/2007WO2007031548A2 Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
03/22/2007CA2622115A1 Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
03/21/2007CN1931827A 2- and 2,5-substituted phenylketo-enols
03/20/2007US7192980 Such as 6-[14-[(aminocarbonyl)oxy]-2,6,12-trihydroxy-5,7,9,11,13,15-hexamethyl-3,8,16,18-nonadecatetraenyl]tetrahydro-(6R)-2H-pyran-2-one; high selectivity; colon cancer
03/20/2007CA2162154C Use of a transition metal complex for the treatment of septic shock
03/15/2007WO2007028814A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
03/15/2007WO2007028412A1 Method for producing lactones
03/15/2007CA2621314A1 Crystalline forms of 1-chloro-4-(.beta.-d-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments
03/14/2007EP1040103B1 Anilide derivative, production and use thereof
03/14/2007CN1930142A Antiinflammatory lactones
03/14/2007CN1930141A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
03/13/2007CA2263336C Neuraminic acid compounds
03/08/2007US20070055081 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones
03/08/2007CA2620566A1 Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
03/07/2007EP1760067A2 Compounds with protected hydroxy groups
03/07/2007EP1758875A1 Chiral heptyne derivatives for the preparation of epothilones and processes for their preparation
03/07/2007CN1925862A Treatment of diseases associated with the EGR-1 enhancer element
03/07/2007CN1923820A Novel carboxylic acid derivatives, their preparation and use
03/07/2007CN1923797A Pharmaceutical compounds
03/07/2007CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186709 Subjecting a vinyl ethers and an unsaturated ketoester to suitable conditions to generate a scaffold having the core dihydropyrancarboxamide or dihydropyrancarboxylic ester or acid; anticarcinogenic agents
03/06/2007CA2202228C Novel retinoids
03/01/2007WO2007025304A2 Process for preparing saccharinic acids and lactones
03/01/2007DE102005038770A1 Mittel zum Färben von keratinhaltigen Fasern Formulations for coloring keratin-containing fibers
02/2007
02/28/2007EP1757583A1 Process for producing cyclic n-hydroxyimide compound
02/28/2007EP1756044A1 Therapeutic compounds
02/28/2007EP1756043A1 Ortho substituted aryl or heteroaryl amide compounds
02/28/2007EP1755586A2 Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
02/28/2007CN1922165A 3-(4-benzyloxyphenyl)propanoic acid derivative
02/28/2007CN1301993C Dimeric compounds and their use as anti-viral agents
02/27/2007US7183421 Such as aldehyde, ketone, lactone, carboxylic acid ester, and carboxylic acid; by causing silica gel to carry the alcohol compound and N-oxyl compounds or corresponding N-hydroxy compounds as oxidation catalysts, and subjecting the alcohol compound to an electrolytic oxidation; organic solvent-free
02/22/2007WO2007021858A2 Methods of making radiolabeled tracers and precursors thereof
02/22/2007WO2006119402A3 C-linked glucoronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth
02/22/2007US20070043223 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
02/22/2007US20070043221 exemplified by Pyrrole Ester O-benzyl lactol methyl acetal
02/22/2007US20070043107 subjecting 4-acyl-4-alkoxycarbonyltetrahydropyran to decarboxylation in the presence of a mineral acid (sulfuric acid or hydrochloric acid) in a solvent e.g.ethanol
02/22/2007CA2618988A1 Methods of making radiolabeled tracers and precursors thereof
02/21/2007EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
02/21/2007EP1753858A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
02/21/2007CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/20/2007US7179912 Materials and methods to potentiate cancer treatment
02/20/2007US7179800 Cannabinoids
02/15/2007WO2007018954A2 Application of a bioactive agent in a solvent composition to produce a target particle morphology
02/15/2007WO2007018953A1 Preparation of nanoparticles
02/15/2007WO2007018887A2 Application of a bioactive agent to a substrate
02/15/2007WO2007017695A2 Dihydroxyanthraquinones and their use
02/15/2007WO2007002109A3 Multidentate pyrone-derived chelators for medicinal imaging and chelation
02/15/2007WO2006055472A3 Synthetic discodermolide analogs
02/15/2007WO2005092897A3 2,4,6-phenylsubstituted cyclic ketoenoles
02/15/2007US20070037976 Method for producing an optically active nitro compound
02/15/2007US20070037973 reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction
02/15/2007US20070037890 Cannabinoids
02/15/2007US20070037838 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof
02/15/2007CA2618069A1 Dihydroxyanthraquinones and their use
02/14/2007CN1300133C Process for synthesis of (3R,5R)-3-hydroxy-5-amino ethyl cyclo-valerolactone
02/14/2007CN1300132C Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/08/2007WO2006021420B1 Method for the production of diarylcycloalkyl derivatives
02/08/2007US20070032545 Antibiotic fki-1778 and process for producing the same
02/07/2007EP1748977A1 Method for producing 1-hydroxymethyl-1,3,5-triazapentane, trihydrochloride
02/07/2007EP1506211B1 C-aryl glucoside sglt2 inhibitors and method
02/07/2007CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
02/07/2007CN1910141A Diamino alcohols and their use as renin inhibitors
02/07/2007CN1298714C Process to produce 4-hydroxy-2-oxo-pyrone derivates useful as protease inhibitors
02/06/2007US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones
02/01/2007WO2006127871A3 Cycloalkylidene compounds as selective estrogen receptor modulators
02/01/2007US20070027112 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 129